Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1-7 randomised controlled trials

Mann Johannes F. E.; Hansen Thomas; Idorn Thomas; Leiter Lawrence A.; Marso Steven P.; Rossing Peter; Seufert Jochen; Tadayon Sayeh; Vilsboll Tina

首页> 外文期刊>The lancet. Diabetes & endocrinology. >Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1-7 randomised controlled trials

【24h】

Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1-7 randomised controlled trials

机译：2型糖尿病患者肾功能和安全对2型糖尿病患者的影响：持续1-7型随机对照试验的患者分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background Patients with type 2 diabetes have a high risk of developing chronic kidney disease. We examined the effects of semaglutide on kidney function and safety in a large, broad type 2 diabetes population.

机译：背景2型糖尿病患者发展为慢性肾病的风险很高。我们在大量广泛的2型糖尿病人群中研究了Semalutide对肾功能和安全性的影响。

著录项

来源
《The lancet. Diabetes & endocrinology.》 |2020年第11期|共14页
作者
Mann Johannes F. E.; Hansen Thomas; Idorn Thomas; Leiter Lawrence A.; Marso Steven P.; Rossing Peter; Seufert Jochen; Tadayon Sayeh; Vilsboll Tina;
展开▼
作者单位

KfH Kidney Ctr D-80804 Munich Germany;

Novo Nordisk Soborg Denmark;

Novo Nordisk Soborg Denmark;

Univ Toronto Knowledge Inst St Michaels Hosp Toronto ON Canada;

HCA Midwest Heart &

Vasc Inst Overland Pk KS USA;

Steno Diab Ctr Copenhagen Gentofte Denmark;

Univ Freiburg Div Endocrinol &

Diabetol Dept Med 2 Med Ctr Fac Med Freiburg Germany;

Novo Nordisk Soborg Denmark;

Univ Copenhagen Steno Diab Ctr Copenhagen Hellerup Denmark;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献

1. Efficacy and Safety of SGLT2 Inhibitors in Patients with Type 1 Diabetes: A Meta-analysis of Randomized Controlled Trials [J] . Yingying Yang, Hui Pan, Bo Wang, 中国医学科学杂志（英文版） . 2017,第001期
2. Efficacy and Safety of Avandamet or Uptitrated Metformin Treatment in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Alone: A Multicenter, Randomized,Controlled Trial [J] . Xiao-Ling Cai, Ying-Li Chen, Jia-Jun Zhao, 中华医学杂志（英文版） . 2015,第010期
3. Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial [J] . Lingvay Ildiko, Catarig Andrei-Mircea, Frias Juan P., The lancet. Diabetes & endocrinology. . 2019,第11期

机译：每次每周半蛋白质的疗效和安全性与2型糖尿病患者的二甲双胍（持续8）中的加载作用和安全性：双盲，第3B阶段，随机对照试验
4. Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial [J] . Sorli Christopher, Harashima Shin-ichi, Tsoukas George M., The lancet. Diabetes & endocrinology. . 2017,第4期

机译：患有2型糖尿病患者的一次每周半蛋白质单药治疗的疗效和安全性（持续1）：双盲，随机，安慰剂控制，平行群，跨国，多元相3A试验
5. Impact of baseline characteristics and beta-cell function on the efficacy and safety of subcutaneous once-weekly semaglutide: A patient-level, pooled analysis of the SUSTAIN 1-5 trials [J] . Vanita R.Aroda, Matthew S. Capehorn, Louis Chaykin, Diabetes, obesity & metabolism . 2020,第3期

机译：基线特征和β细胞功能对皮下一次每周半蛋白质的疗效和安全性的影响：患者水平，汇总分析的维持1-5试验
6. Randomised Controlled Trial of an In-Home Monitoring Intervention to Improve Health Outcomes for Type 2 Diabetes: Study Protocol [C] . Karen CARLISLE, Robin WARREN, Paul SCUFFHAM, Global Telehealth (Conference) . 2012

机译：随机对照试验的内部监测干预以改善2型糖尿病的健康结果：研究方案
7. Impact of a challenge intervention on weight control in pediatric patients with kidney disease and diabetes: A retrospective analysis of patient records. [D] . Sanderson, Lori. 2010

机译：挑战性干预对小儿肾脏疾病和糖尿病患者体重控制的影响：患者记录的回顾性分析。
8. Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [O] . Fang-Hong Shi, Hao Li, Min Cui, 2018

机译：每周一次塞马鲁肽治疗2型糖尿病的疗效和安全性：随机对照试验的系统评价和荟萃分析
9. Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial [O] . Ildiko Lingvay, Andrei-Mircea Catarig, Juan P Frias, 2019

机译：患有2型糖尿病患者的疗效和每日半蛋白酶和每日蜜碳增蛋白的疗效和安全性（持续8）：双盲，第3B期，随机对照试验
10. Effects of Intensive Diabetes Therapy on Neuropsychological Function in Adults inthe Diabetes Control and Complications Trial. Analysis Documentation [R] . 1997

机译：强化糖尿病治疗对糖尿病控制和并发症患者神经心理功能的影响。分析文档

Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1-7 randomised controlled trials

摘要

著录项

相似文献

相关主题

期刊订阅